Arcticzymes Technologies ASA represents values of innovation, collaboration, and sustainability. As a company, Arcticzymes is dedicated to providing high-quality products and services to the life sciences industry. They strive to continuously develop and improve their enzyme technologies, offering innovative solutions for research, diagnostics, and therapeutics. Arcticzymes values collaboration, actively working with partners and customers to meet diverse scientific needs. Furthermore, the company is committed to sustainability by implementing environmentally friendly processes and promoting responsible business practices. Arcticzymes Technologies ASA embodies a corporate philosophy centered around excellence, integrity, and contributing to advancements in the life sciences field.

Arcticzymes Technologies ASA is primarily present in a number of countries and regions worldwide. The company has a global presence, with a strong focus on Europe, specifically within the Nordic region. Additionally, Arcticzymes Technologies ASA has established a significant presence in North America, specifically in the United States and Canada. The company's broad geographic reach allows it to cater to a wide range of international customers and partnerships.

Arcticzymes Technologies ASA has achieved several significant milestones. The company has developed a reputation as a leader in the field of molecular biology enzymes and technologies. Among their notable achievements is the successful development and commercialization of innovative enzymes used in various applications, such as PCR and DNA sequencing. They have also established strong partnerships with renowned research institutions, leading to the creation of cutting-edge products. Arcticzymes Technologies ASA has continuously invested in research and development to enhance their product portfolio and expand their market presence. Their commitment to scientific excellence and customer satisfaction has propelled them to become a trusted name in the industry.

Arcticzymes Technologies ASA is a Norwegian biotechnology company specializing in the development and production of novel enzymes for molecular biology applications. Founded in 2002, Arcticzymes has a rich history of providing innovative solutions to the life science industry. With a focus on marine enzymes, the company has developed a diverse portfolio of products that find applications in research, diagnostics, and therapeutics. Arcticzymes is committed to sustainability and sources its enzymes from diverse Arctic marine organisms, ensuring minimal impact on the environment. The company's dedication to quality, innovation, and environmental responsibility has made Arcticzymes Technologies ASA a trusted partner in the global biotech community.

Arcticzymes Technologies ASA faces competition from several companies in the market. Some of its main competitors include Company A, Company B, and Company C. These competitors offer similar products and services, presenting options for customers seeking alternatives to Arcticzymes Technologies ASA. However, Arcticzymes Technologies ASA maintains its unique value proposition through its innovative technologies and unparalleled expertise, ensuring its position as a leading player in the market.

Arcticzymes Technologies ASA primarily operates within the biotechnology industry.

The business model of Arcticzymes Technologies ASA revolves around the development and production of high-quality enzymes for use in molecular research, diagnostics, and therapeutics. With a focus on the cold-adapted enzyme market, Arcticzymes utilizes its expertise to provide biotechnology companies and research institutions with innovative enzymes. By leveraging its unique access to Arctic marine resources, the company is able to produce enzymes with exceptional properties, such as increased stability and activity at low temperatures. Arcticzymes' business model aims to cater to the growing demand for specialized enzymes in various industries, offering effective solutions for customers globally.

Arcticzymes Technologies A의 P/E 비율은 44.13입니다.

Arcticzymes Technologies A의 P/S 비율은 8.21입니다.

Arcticzymes Technologies A에 대한 AlleAktien 품질 점수는 3/10입니다.

예상되는 Arcticzymes Technologies A 매출은 130.29 백만 NOK입니다.

예상되는 Arcticzymes Technologies A 이익은 24.24 백만 NOK입니다.

Arcticzymes Technologies ASA is a Norwegian biotechnology company specializing in the production of enzymes for use in molecular biology, diagnostics, and therapeutics. The company was founded in 2002 and is headquartered in Tromsø, Norway. It is divided into three business areas: enzymes, reagents, and custom solutions. The enzyme business is the core business of Arcticzymes Technologies ASA, offering a wide range of enzymes for various applications. The reagents category includes various reagents for molecular biology, including buffers, gels, and dyes for gel electrophoresis, as well as RT-qPCR reagents for real-time polymerase chain reaction. The company also offers custom solutions for customers, developing tailored enzymes or reagents for specific applications. Arcticzymes Technologies ASA emphasizes continuous innovation, investing in research and development to develop new enzymes and reagents. It also collaborates with other companies and research institutes to advance its R&D efforts and develop new products. Overall, Arcticzymes Technologies ASA focuses on producing enzymes and reagents for molecular biology and diagnostics, offering high-quality products and actively investing in R&D.

Arcticzymes Technologies A은(는) 연간 번의 배당을 통해 0 NOK의 배당금을 지급합니다.

Arcticzymes Technologies A의 현재 배당금은 계산할 수 없거나, 회사가 배당금을 지급하지 않습니다.

Arcticzymes Technologies A의 ISIN은 NO0010014632입니다.

Arcticzymes Technologies A의 WKN은 A0HGR5입니다.

Arcticzymes Technologies A의 티커는 AZT.OL입니다.

지난 12개월 동안 Arcticzymes Technologies A은(는) 의 배당금을 지급했습니다. 이는 약 의 배당 수익률에 해당합니다. 향후 12개월 동안 Arcticzymes Technologies A은(는) 0 NOK의 배당금을 지급할 것으로 예상됩니다.

Arcticzymes Technologies A의 현재 배당 수익률은 입니다.

Arcticzymes Technologies A은 분기별로 배당금을 지급합니다. 이는 월에 배당됩니다.

Arcticzymes Technologies A은(는) 지난 0년 동안 매년 배당금을 지급했습니다.

향후 12개월 동안 0 NOK의 배당금이 예상됩니다. 이는 배당수익률 0 %에 해당합니다.

Arcticzymes Technologies A은 '건강' 섹터에 속합니다.

Arcticzymes Technologies A의 마지막 배당금을 0 NOK만큼 받기 위해선 의 Ex-Tag 전에 주식을 보유하고 있어야 했습니다.

마지막 배당금 지급일은 입니다.

2023년에 Arcticzymes Technologies A는 0 NOK를 배당금으로 지급했습니다.

Arcticzymes Technologies A의 배당금은 NOK에 지급됩니다.